Pharma.Aero unveils the White Paper, marking the completion of its first series of projects delving into sustainability challenges within healthcare supply chain logistics.

The document showcases the findings of the Green Air Pharma Logistics Project with a Focus on Green Lane. It introduces a comprehensive index – the Lane Sustainability Readiness Index (LSRI) – to measure the sustainability readiness of stakeholders across the airport-to-airport supply chain.

READ: Flying fish from Japan: American Airlines Cargo hit a new record

The GAPL Project was a collaborative effort aimed at identifying key quantitative and qualitative indicators defining a green air lane. It involved various stakeholders along the supply chain, including life science manufacturers, airports, airlines, cargo handlers, and solution providers.

The project proposes the Lane Sustainability Readiness Index to support life science companies and freight forwarders in integrating sustainability considerations into freight procurement and lane assessment processes as part of their efforts to achieve Scope 3 targets. Additionally, it aims to support freight forwarders and airlines in developing low-emissions products and value propositions aligned with their customers’ sustainability goals.

“The decarbonisation of air transportation is a multifaceted journey,” remarks Ms Jaisey Yip, project lead and vice President of the Cargo Business Division at Changi Airport Group, a strategic member of Pharma.Aero. Beyond the life science industry, the Lane Sustainability Readiness Index (LSRI) is cross-sectoral and aims to provide value to all stakeholders within the air cargo value chain.”

Ms Yip adds, “The GAPL project paves the way for Pharma.Aero and the industry should explore new avenues towards more sustainable air logistics. We anticipate the LSRI’s application beyond the airport-to-airport boundary.”

Sara Van Lerberghe, Pharma.Aero Projects Coordinator emphasises the project’s collaborative methods, leveraging the collective expertise of Pharma. Aero’s global membership: “We commend all our members and partners for their invaluable contributions to this project. Their dedication was pivotal in acquiring firsthand insights into industry sustainability objectives and identifying essential indicators for evaluating lane sustainability readiness.”

READ: Menzies Aviation funds planting of 70,000 mangroves

Pharma. Aero acknowledges that sustainability is a rapidly evolving concept and remains committed to updating the LSRI to meet the industry’s changing needs. The project also outlines potential spin-off projects to achieve sustainable air pharma logistics, including developing a centralised digital platform and expanding beyond airport-to-airport scope.